Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Novlead Biotech Logo
Novlead Biotech Growth Score
74
CB Rank
52444
Heat Score
76
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Founded
obfuscation
PrivateSeries C Nanjing, Jiangsu, China101-250 www.novlead.com/en/index.html
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Novlead Biotech
Total Funding
obfuscation
Growth Score
74
Heat Score
76

Total Funding
obfuscation
Series C raised
obfuscation
Growth Score74
-1 pts
in past quarter
Heat Score 76
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Novlead Biotech

CB Rank
52444
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Founded
obfuscation
PrivateSeries C Nanjing, Jiangsu, China101-250 www.novlead.com/en/index.html
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Series C
OBF
in
obfuscation
Series C
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Key People

Details

Legal Name NANJING NOVLEAD BIOTECHNOLOGY CO.,LTD
Also Known As Novlead Bio, Nuoling Bio, Noring Biotech, Nanjing Nuoling Biotechnology Co., Ltd., 诺令生物, Norling Biotech, Nolin Biotech, Noling Bio
Operating Status Active
Company Type For Profit
Founders  Wen Mao
About the Company
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Phone Number +86-25-58131291
Contact Email contact@novlead.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

iNOwill Series
A nitric oxide inhalation therapy device that generates high-purity NO gas via electrochemical catalytic reduction, providing up to 500 hours of continuous output without the need for gas cylinders.
eNOaire Series
A nitric oxide therapy device that generates NO gas on demand from dry air using an electric arc method, featuring independent NO delivery and monitoring systems for stable and portable clinical use.

Research & Development

Novlead Biotech is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C
obfuscation
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
6
obfuscation
Dingxin CapitalSeries C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Guojin Group Logo
Guojin Group
—
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
—
Guojin Group Logo
Guojin Group
—
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
—
Guojin Group Logo
Guojin Group
—
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
—
Guojin Group Logo
Guojin Group
—
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
—
Guojin Group Logo
Guojin Group
—
Series C - Novlead Biotech Logo
Series C - Novlead Biotech
—
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 4

Employee Profiles

News

News and Press

News•Jun 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 27, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 27, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 14, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

521
357.02%
 in past month

IT Spend

$218KThis year, Novlead Biotech is projected to spend $218K on IT, according to Aberdeen.

Active Website Tech Count

18Novlead Biotech is actively using 18 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

3Novlead Biotech has registered 3 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Novlead Biotech's headquarters? Novlead Biotech is located in Nanjing, Jiangsu, China.Who invested in Novlead Biotech? Novlead Biotech has 11 investors including Guojin Group and  Dingxin Capital.When was the last funding round for Novlead Biotech? Novlead Biotech closed its last funding round on
obfuscation
from a Series C round.Who are Novlead Biotech's competitors? Alternatives and possible competitors to Novlead Biotech may include Vero Biotech, CF PharmTech, and  Third Pole.How much funding has Novlead Biotech raised to date? Novlead Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|